Novozymes A/S (OTCMKTS:NVZMY) Stock Crosses Below Fifty Day Moving Average – Time to Sell?

Novozymes A/S (OTCMKTS:NVZMY)’s stock price crossed below its fifty day moving average during trading on Tuesday. The stock has a fifty day moving average of $67.32 and traded as low as $65.9101. Novozymes A/S shares last traded at $66.25, with a volume of 352,236 shares trading hands.

Novozymes A/S Price Performance

The company has a current ratio of 1.74, a quick ratio of 1.04 and a debt-to-equity ratio of 0.25. The business has a 50-day moving average price of $67.32 and a two-hundred day moving average price of $62.69. The firm has a market capitalization of $27.46 billion, a price-to-earnings ratio of 39.20, a PEG ratio of 3.08 and a beta of 0.86.

Novozymes A/S (OTCMKTS:NVZMY) last announced its quarterly earnings results on Thursday, November 5th. The biotechnology company reported $0.48 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.74 by ($0.26). Novozymes A/S had a return on equity of 6.56% and a net margin of 15.59%. The company had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.28 billion. As a group, research analysts forecast that Novozymes A/S will post 2.45 EPS for the current year.

Institutional Investors Weigh In On Novozymes A/S

A hedge fund recently raised its stake in Novozymes A/S stock. Elefante Mark B raised its stake in Novozymes A/S (OTCMKTS:NVZMY) by 73.5% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 5,900 shares of the biotechnology company’s stock after buying an additional 2,500 shares during the quarter. Elefante Mark B’s holdings in Novozymes A/S were worth $371,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 0.03% of the company’s stock.

Novozymes A/S Company Profile

Novozymes A/S was a Denmark-based biotechnology company that developed and produced enzymes and microorganisms for industrial and consumer applications. Its solutions were used in areas including household care, food and beverages, agriculture, animal health and bioenergy. The company’s products included enzymes used in detergents, baking, brewing and biofuel production, as well as microbial solutions for agricultural and other industrial processes. Novozymes served customers in markets around the world.